Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice

Neurobiology of Disease

Volumn 12, Issue 2, 2003, Pages 150-161

  Crocker, S J ^a   Liston, P ^b,c   Anisman, H ^d   Lee, C J ^a   Smith, P D ^a   Earl, N ^b   Thompson, C S ^a   Park, D S ^a   Korneluk, R G ^b,c   Robertson, G S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Aegera Therapeutics Inc   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d CARLETON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; INHIBITOR OF APOPTOSIS PROTEIN; NEURON SPECIFIC ENOLASE; NEUROTOXIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; MALE; MOUSE; NERVE CELL LESION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

EID: 0345268775     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(02)00020-7     Document Type: Article

References (79)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:1946;239-247.
2. Agid Y., Javoy F., Glowinski J. Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigro-striatal dopaminergic system in the rat. Nature. 245:1973;15-16.
3. Bernard R., Dieni S., Rees S., Bernard O. Physiological and induced neuronal death are not affected in NSE-bax transgenic mice. J. Neurosci. Res. 52:1998;247-259.
4. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seiterberger F. Brain dopamine and syndromes of Parkinson and Huntington Clinical, morphological, and neurochemical correlations . J. Neurol Sci. 20:1973;415-455.
5. Bilsland J., Roy S., Xanthoudakis S., Nicholson D.W., Han Y., Grimm E., Hefti F., Harper S.J. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons. J. Neurosci. 22:2002;2637-2649.
6. Blanchard D.C., Griebel G., Blanchard R.J. Mouse defensive behaviours pharmacological and behavioural assays for anxiety and panic . Neurosci. Behav. Rev. 25:2001;205-218.
7. Blanchard R.J., Yudko E.B., Rodgers R.J., Blanchard D.C. Defense system psychopharmacology an etiological approach to the pharmacology of fear and anxiety . Behav. Brain Res. 58:1993;155-165.
8. Borden K.L., Freemont P.S. The RING finger domain a recent example of a sequence-structure family . Curr. Opin. Struct. Biol. 6:1996;395-401.
9. Chai J., Shiozaki E., Srinivasula S.M., Wu Q., Datta P., Alnemri E.S., Shi Y., Dataa P. Structural basis of caspase-7 inhibition by XIAP. Cell. 104:2001;769-780.
10. Crocker, S.J., Lamba, W.R., Smith, P.D., Callaghan, S.M., Slack, R.S., Anisman, H., Park, D.S., 2001a. c-Jun mediates axotomy-induced dopamine neuron death in vivo. Proc. Natl. Acad. Sci. USA 98.
11. Crocker S.J., Wigle N., Liston P., Thompson C.S., Lee C.J., Xu D., Roy S., Nicholson D.W., Park D.S., MacKenzie A., Korneluk R.G., Robertson G.S. NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6OHDA rat model of Parkinson's disease. Eur. J. Neurosci. 14:2001;391-400.
12. Deveraux Q.L., Reed J.C. IAP family proteins - suppressors of apoptosis. Genes Dev. 13:1999;239-252.
13. Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. Xlinked IAP is a direct inhibitor of cell-death proteases. Nature. 388:1997;300-304.
14. Deveraux Q.L., Leo E., Stennicke H.R., Welsh K., Salvesen G.S., Reed J.C. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 18:1999;5242-5251.
15. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NfκB signaling cascades. Nature. 412:2001;641-647.
16. Eberhardt O., Coelin R.V., Kugler S., Lindeneau J., Rathke-Hartlieb S., Gerhardt E., Haid S., Isenman S., Gravel C., Srinivasen A., Bahr M., Weller M., Dichgans J., Schulz J.B. Protection by synergistic effects of adenovirus-mediated Xchromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neurosci. 20:2000;9126-9134.
17. Farahani R., Fong W.G., Korneluk R.G., MacKenzie A.E. Genomic organization and primary characterization of miap-3 the murine homologue of human X-linked IAP . Genomics. 42:1997;514-518.
18. Forss-Petter S., Danielson P., Catsicas S., Battenberg E., Price J., Nerenberg M., Sutcliffe J.G. Transgenic mice expressing b-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron. 5:1990;187-197.
19. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. second ed:2001;Academic Press, New York.
20. Garg A., Aggarwal B.B. Nuclear transcription factor kappa-B as a target for cancer drug development. Leukemia. 16:2002;1053-1068.
21. Hagg T., Varon S. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl. Acad. Sci. USA. 90:1993;6315-6319.
22. Hayley S., Brebner K., Lacosta S., Merali Z., Anisman H. Sensitization to the effects of tumor necrosis factor-a Neuroendocrine, central monoamine, and behavioural variations . J. Neurosci. 19:1999;5654-5665.
23. Hefti F., Melamed E., Wurtman R.J. Partial lesions of the dopaminergic nigrostriatal system in the brain biochemical characterization . Brain Res. 195:1980;95-122.
24. Hofer-Warbinek R., Schmid J.A., Stehlik C., Binder B.R., Lipp J., de Martin R. Activation of NF-κB by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem. 275:2000;22064-22068.
25. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45:1986;19-34.
26. Huang Q., Deveraux Q.L., Maeda S., Salvesen G.S., Stennicke H.R., Hammock B.D., Reed J.C. Evolutionary conservation of apoptosis mechanisms Lepidopteran and baculoviral inhibitor of apoptosis proteins are inhibitors of mammalian caspase-9 . Proc. Natl. Acad. Sci. USA. 97:2000;1427-1432.
27. Huang Y., Park Y.C., Rich R.L., Segal D., Myszka D.G., Wu H. Structural basis of caspase inhibition by XIAP differential roles of the linker versus the BIR domain . Cell. 104:2001;781-790.
28. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.P., Ruberg M., Faucheux B.A., Agid Y., Hirsch E.C. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson's disease. Proc. Natl. Acad. Sci. USA. 94:1997;7531-7536.
29. Jackson-Lewis V., Jakowec M., Burke R.E., Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration. 4:1995;257-269.
30. Karin M., Cao Y., Greten F.R., Li Z.-W. NF-κB in cancer from innocent bystander to major culprit . Nature Rev. Cancer. 2:2002;301-310.
31. Korhonen L., Belluardo N., Lindholm D. Regulation of X-chromosome-linked inhibitor of apoptosis protein in kainic acid-induced neuronal death in the rat hippocampus. Mol. Cell. Neurosci. 17:2001;364-372.
32. Kugler S., Straten G., Kreppel F., Isenmann S., Liston P., Bahr M. The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ. 7:2000;815-824.
33. Kuida K., Zheng T.S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:1996;368-372.
34. Kuida K., Haydar T.F., Kuan C.Y., Gu Y., Taya C., Karasuyama H., Su M.S., Rakic P., Flavell R.A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase-9. Cell. 94:1998;325-337.
35. LaCasse E.C., Baird S., Korneluk R.G., MacKenzie A.E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 17:1998;3247-3259.
36. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
37. Levkau B., Garton K.J., Ferri N., Kloke K., Nofer J.R., Baba H.A., Raines E.W., Breithardt G. XIAP induces cell-cycle arrest and activates nuclear factor-kappaB new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells . Circ. Res. 88:2001;282-290.
38. Li J., Kim J.-M., Liston P., Li M., Miyazaki T., MacKenzie A.E., Korneluk R.G., Tsang B.K. Expression of inhibitor of apoptosis proteins (IAPs) in rat granulosa cells during ovarian follicular development and atresia. Endocrinology. 139:1998;1321-1328.
39. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nature Med. 5:1999;1403-1409.
40. Liston P., Roy N., Tamai K., Lefebvre C., Baird S., Cherton-Horvat G., Farahani R., McLean M., Ikeda J.E., MacKenzie A., Korneluk R.G. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 379:1996;349-353.
41. Martinou J.C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
42. Mercer E.A., Korhonon L., Skoglosa Y., Olsson A., Kukkonen J.P., Lindholm D. NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3 dependent and independent pathways. EMBO J. 19:2000;1-11.
43. Miller L.K. An exegesis of IAPs salvation and surprises from BIR motifs . Trends Cell Biol. 9:1999;323-328.
44. Offen D., Beart P.M., Cheung N.S., Pascoe C.J., Hochman A., Gorodin S., Melamed E., Bernard R., Bernard O. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc. Natl. Acad. Sci. USA. 95:1998;5789-5794.
45. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;453-501.
46. Paxinos G., Franklin K.B.J. Mouse Brain in Stereotaxic Coordinates. second ed. 2001;Academic Press, New York.
47. Perrelet D., Ferri A., Liston P., Muzzin P., Korneluk R.G., Kato A.C. IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo. Nature Cell Biol. 4:2002;175-179.
48. Perrelet D., Ferri A., MacKenzie A.E., Smith G.M., Korneluk R.G., Liston P., Sagot Y., Terrado J., Monnier D., Kato A.C. IAP family proteins delay motoneuron cell death in vivo. Eur. J. Neurosci. 12:2000;2059-2067.
49. Petroske E., Meredith G.E., Callen S., Totterdell S., Lau Y.S. Mouse model of Parkinsonism a comparison between subacute MPTP and chronic MPTP/probenecid treatment . Neuroscience. 106:2001;589-601.
50. Phillips P. Several classes of new drugs emerging for Parkinson disease. J. Am. Med. Assoc. 282:1999;929-931.
51. Przedborski S., Jackson-Lewis V., Djaldetti R., Liberatore G., Vila M., Vukosavic S., Almer G. The parkinsonian toxin MPTP action and mechanism . Restor. Neurol Neurosci. 16:2000;135-142.
52. Reinhard J.F. Jr., Miller D.B., O'Callaghan J.P. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum evidence for glial response to injury . Neurosci. Lett. 95:1988;246-251.
53. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun C., Fesik S.W., Liddington R.C., Salvesen G.S. Structural basis for the inhibition of caspase-3 by XIAP. Cell. 104:2001;791-800.
54. Sanna M.G., Duckett C.S., Richter W.M., Thompson C.B., Ulevitch R.J. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc. Natl. Acad. Sci. USA. 95:1998;6015-6020.
55. Sanna M.G., da Silva Correia J., Ducrey O., Lee J., Nomoto K., Schrantz N., Deveraux Q.L., Ulevitch R.J. IAP suppression of apoptosis involves distinct mechanisms the TAK1/JNK1 signaling cascade and caspase inhibition . Mol. Cell. Biol. 22:2002;1754-1766.
56. Sasaki H., Sheng Y., Kotsuji F., Tsang B.K. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res. 60:2000;5659-5666.
57. Schmecel D.E., Marangos P.J. Neuron specific enolase as a marker for differentiation in neurons and neuroendocrine cells. Barker J., McKelvey J. Current Methods in Cellular Neurobiology. 1983;1-62 Wiley, New York.
58. Sedelis M., Schwarting R.K.W., Huston J.P. Behavioural phenotyping of the MPTP mouse model of Parkinson's disease. Behav. Brain Res. 125:2001;109-122.
59. Stehlik C., de Martin R., Kumabashiri I., Schmid J.A., Binder B.R., Lipp J. Nuclear factor (NF) kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188:1998;211-216.
60. Sun C., Cai M., Meadows R.P., Xu N., Gunasekera A.H., Herrmann J., Wu J.C., Fesik S.W. NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP. J. Biol. Chem. 275:2000;33777-33781.
61. Suzuki Y., Nakabayashi Y., Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. USA. 98:2001;8662-8667.
62. Takahashi R., Deveraux Q., Tamm I., Welsh K., Assa-Munt N., Salvesen G.S., Reed J.C. A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem. 273:1998;7787-7790.
63. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
64. Tseng J.L., Baetge E.E., Zurn A.D., Aebischer P. GDNF reduces drug-induced rotational behaviour after medical forebrain bundle transection by a mechanism not involving striatal dopamine. J. Neurosci. 17:1997;325-333.
65. Turmel H., Hartmann A., Parain K., Douhou A., Srinivasan A., Agid Y., Hirsch E.C. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Mov. Disord. 16:2001;185-189.
66. Uren A.G., Coulsen E.J., Vaux D.L. Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeast. Trends Biochem. Sci. 23:1998;159-162.
67. Van der Zee C.E.E.M., Hagg T. Delayed NGF infusion fails to reverse axotomy-induced degeneration of basal forebrain cholinergic neurons in adult p75LNTR-deficient mice. Neuroscience. 110:2002;641-651.
68. Viswanath V., Wu Z., Fonck C., Wei Q., Boonplueang R., Andersen J.K. Transgenic mice neuronally expression baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration. Proc. Natl. Acad. Sci. USA. 97:2000;2270-2275.
69. Weihmuller F.B., Hadjiconstantinou M., Bruno J.P. Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice. Neurosci. Lett. 85:1988;137-142.
70. Weston C.R., Davis R.J. The JNK signal transduction pathway (2002). Curr. Opin. Genet. Dev. 12:2002;14-21.
71. Willis G.L., Donnan G.A. Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice. Brain Res. 402:1987;269-274.
72. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J. Neurosci. 22:2002;1763-1771.
73. Xu D., Bureau Y., Mclntyre D.C., Nicholson D.W., Liston P., Zhu Y., Fong W.G., Crocker S.J., Korneluk R.G., Robertson G.S. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J. Neurosci. 19:1999;5026-5033.
74. Xu D.G., Korneluk R.G., Tamai K., Wigle N., Hakim A., MacKenzie A.E., Robertson G.S. Distribution of neuronal apoptosis inhibitory protein-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 382:1997;247-259.
75. Xu D.G., Crocker S.J., Doucet J.P., St-Jean M., Tamai K., Hakim A.M., Ikeda J.E., Liston P., Thompson C.S., Korneluk R.G., MacKenzie A., Robertson G.S. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Med. 3:1997;997-1004.
76. Yamaguchi K., Nagai S., Ninomiya-Tsuji J., Nishita M., Tamai K., Irie K., Ueno N., Nishida E., Shibuya H., Matsumoto K. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J. 18:1999;179-187.
77. Yang Y., Fang S., Jensen J.P., Weissman A.M., Ashwell J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 288:2000;874-877.
78. Yang Y.L., Li X.M. The IAP family endogenous caspase inhibitors with multiple biological activities . Cell Res. 10:2000;169-177.
79. Zigmond M.J., Hastings T.G. Neurochemical responses to lesions of dopaminergic neurons implications for compensation and neuropathology . Adv. Pharmacol. 42:1998;788-792.